J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, X.
Right arrow Articles by McLachlan, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, X.
Right arrow Articles by McLachlan, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HERBAL MEDICINE

Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach

Xuemin Jiang, PhD, Elaine Y. L. Blair, PhD and Andrew J. McLachlan, PhD

From the Faculty of Pharmacy, the University of Sydney, Australia (Dr Jiang, Dr Blair, Dr McLachlan); the Department of Medicine, University of Chicago, Chicago, Illinois (Dr Jiang); the Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, Australia (Dr McLachlan); and Sanofi-Aventis, Sydney, Australia (Dr Blair).

Systematic evidence regarding herb-drug interactions is lacking. This study investigated herb-drug interactions with warfarin. S-warfarin concentration and response (prothrombin complex activity) data from healthy subjects (n = 24) who received a single warfarin dose (25 mg) and either St John's wort, Asian ginseng, Ginkgo biloba, or ginger were analyzed using a population pharmacokinetic-pharmacodynamic modeling approach. The ratio of S-warfarin apparent clearance (CL/F) compared to control was 1.39 ± 0.06 and 1.14 ± 0.04 after St John's wort and Asian ginseng pretreatment, respectively. Other pharmacokinetic and pharmacodynamic parameters were unaffected. Coadministration of St John's wort significantly increased S-warfarin CL/F, whereas treatment with Asian ginseng produced only a moderate increase in CL/F. Ginkgo and ginger did not affect the pharmacokinetics of warfarin in healthy subjects. None of the herbs studied had a direct effect on warfarin pharmacodynamics. Studies in anticoagulated patients are warranted to assess the clinical significance of these herb-drug interactions.


Key Words: Warfarinanticoagulantsherb-drug interactionsSt John's wortAsian ginsengginkgogingerpopulation pharmacokinetic-pharmacodynamic modeling

Address for reprints: Professor Andrew J. McLachlan, PhD, Faculty of Pharmacy, Building A15, the University of Sydney, NSW 2006, Australia; e-mail: andrewm{at}pharm.usyd.edu.au.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Complementary Health Practice ReviewHome page
M. N. Bristol, S. S. Sonnad, and C. Guerra
Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients
Complementary Health Practice Review, April 1, 2008; 13(2): 100 - 109.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Clinical Pharmacology